Hallucinogen dependence, in remission
ICD-10 F16.21 is a billable code used to indicate a diagnosis of hallucinogen dependence, in remission.
Hallucinogen dependence, in remission, refers to a state where an individual has previously met the criteria for hallucinogen dependence but is currently not experiencing the symptoms associated with the disorder. Hallucinogens, such as LSD, psilocybin, and mescaline, can lead to significant psychological dependence characterized by a strong desire to use the substance, tolerance, and withdrawal symptoms. In remission indicates that the individual has not engaged in hallucinogen use for a specified period, typically at least 12 months, and is not exhibiting any withdrawal symptoms or cravings. This condition is crucial to identify in treatment settings, as it helps healthcare providers tailor interventions and support for individuals recovering from substance use disorders. Treatment may involve counseling, support groups, and behavioral therapies aimed at preventing relapse and promoting long-term recovery. Accurate coding is essential for appropriate treatment planning and insurance reimbursement.
Detailed history of substance use, treatment history, and current status of remission.
Patients presenting for follow-up after treatment for hallucinogen dependence.
Ensure clear documentation of remission status and any ongoing support or therapy.
Comprehensive mental health assessment, including any co-occurring disorders.
Patients with a history of hallucinogen use presenting with anxiety or mood disorders.
Document any psychiatric evaluations and treatment plans that address both substance use and mental health.
Used during initial evaluations for patients with a history of hallucinogen use.
Comprehensive assessment of substance use history and current status.
Addiction specialists should ensure thorough documentation of all relevant factors.
'In remission' indicates that the individual has not used hallucinogens for a specified period, typically at least 12 months, and is not experiencing withdrawal symptoms or cravings.
